PROF. NDETEI DAVID M
MBChB Nbi., DPM, (Lond), MRCPych (UK), MD Nbi.,
Office: 2716315 Mobile: 0722518365
Email: dmndetei@uonbi.ac.ke
Office: 2716315 Mobile: 0722518365
Email: dmndetei@uonbi.ac.ke
The discovery of the highly active antiretroviral therapy has improved the life span of people living with HIV/AIDS (PLWHA) to almost that of the general population. This, however, has been coupled with increased incidences of HIVassociated dementia, especially mild cognitive impairment. Combined antiretroviral therapy (cART) has been observed to improve neurocognitive functions but the ART regimen that is best suited for improvement of neurocognitive functions is still largely unknown. This study was aimed at determining how neurocognitive deficits in patients on cART were related to ART regimen.